Related references
Note: Only part of the references are listed.Antibodies to watch in 2020
Helene Kaplon et al.
MABS (2020)
High calcium, phosphate and calcitriol supplementation leads to an osteocyte-like phenotype in calcified vessels and bone mineralisation defect in uremic rats
Sarah-Kim Bisson et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2019)
Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!
Vincent M. Brandenburg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Sclerostin is expressed in the atherosclerotic plaques of patients who undergoing carotid endarterectomy
Gaetano Leto et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2019)
High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease
Natalia Carrillo-Lopez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Ossified blood vessels in primary familial brain calcification elicit a neurotoxic astrocyte response
Yvette Zarb et al.
BRAIN (2019)
Bone marrow mesenchymal stem cell-derived exosomes alleviate high phosphorus-induced vascular smooth muscle cells calcification by modifying microRNA profiles
Yan Guo et al.
FUNCTIONAL & INTEGRATIVE GENOMICS (2019)
Calcifications in atherosclerotic plaques and impact on plaque biomechanics
Hilary E. Barrett et al.
JOURNAL OF BIOMECHANICS (2019)
SaO049VASCULAR CALCIFICATION IS ASSOCIATED WITH WNT-SIGNALING PATHWAY AND BLOOD PRESSURE VARIABILITY IN CHRONIC KIDNEY DISEASE RATS
Ruoxi Liao et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Sclerostin as Regulatory Molecule in Vascular Media Calcification and the Bone-Vascular Axis
Annelies De Mare et al.
TOXINS (2019)
Primary familial brain calcifications: genetic and clinical update
Ana Westenberger et al.
CURRENT OPINION IN NEUROLOGY (2019)
Evaluation of the association of Wnt signaling with coronary artery calcification in patients on dialysis with severe secondary hyperparathyroidism
Tzung-Yo Ho et al.
BMC NEPHROLOGY (2019)
Clinical Inference of Serum and Bone Sclerostin Levels in Patients with End-Stage Kidney Disease
Annelies De Mare et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Specific knockdown of WNT8b expression protects against phosphate-induced calcification in vascular smooth muscle cells by inhibiting the Wnt--catenin signaling pathway
Bin-Yao Tian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System
Bin Nie et al.
CURRENT MEDICAL SCIENCE (2019)
Sclerostin/Receptor Related Protein 4 and Ginkgo Biloba Extract Alleviates β-Glycerophosphate-Induced Vascular Smooth Muscle Cell Calcification By Inhibiting Wnt/β-Catenin Pathway
Jian Wang et al.
BLOOD PURIFICATION (2019)
BMP9/COX-2 axial mediates high phosphate-induced calcification in vascular smooth muscle cells via Wnt/β-catenin pathway
Fang He et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis
Heather Fairfield et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know
Pierre Delanaye et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Recombinant sclerostin antagonizes effects of ex vivo mechanical loading in trabecular bone and increases osteocyte lacunar size
M. Kogawa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
Myeloid -Catenin Deficiency Exacerbates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice
Fang Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Sclerostin is not associated with cardiovascular event or fracture in kidney transplantation candidates
Hanne Skou Jorgensen et al.
CLINICAL NEPHROLOGY (2018)
Impact of the Canonical Wnt Pathway Activation on the Pathogenesis and Prognosis of Adamantinomatous Craniopharyngiomas
Carlos Eduardo Barros Juca et al.
HORMONE AND METABOLIC RESEARCH (2018)
Effects of Enoxaparin on Intravascular Sclerostin Release in Healthy Men
Jacek Borawski et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2018)
A Prospective Cohort Study Showing No Association Between Serum Sclerostin Level and Mortality in Maintenance Hemodialysis Patients
Madoka Sato et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
Indoxyl sulfate accelerates vascular smooth muscle cell calcification via microRNA-29b dependent regulation of Wnt/beta-catenin signaling
Han Zhang et al.
TOXICOLOGY LETTERS (2018)
frontiers in Physiology High Mobility Group Box 1 Promotes Aortic Calcification in Chronic Kidney Disease via the Wnt/β-Catenin Pathway
Xiucai Jin et al.
FRONTIERS IN PHYSIOLOGY (2018)
The Interplay of SIRT1 and Wnt Signaling in Vascular Calcification
Francesca Bartoli-Leonard et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2018)
Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II-Induced Aortic Aneurysm and Atherosclerosis
Smriti Murali Krishna et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Suppression of Sclerostin Alleviates Radiation-Induced Bone Loss by Protecting Bone-Forming Cells and Their Progenitors Through Distinct Mechanisms
Abhishek Chandra et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys
Michael S. Ominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Serum sclerostin: relation with mortality and impact of hemodiafiltration
Lotte Lips et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry
Vincent M. Brandenburg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Activation of peroxisome proliferator-activated receptor γ inhibits vascular calcification by upregulating Klotho
Lijuan Cheng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Collagen XIV and a related recombinant fragment protect human vascular smooth muscle cells from calcium-/phosphate-induced osteochondrocytic transdifferentiation
Christian Freise et al.
EXPERIMENTAL CELL RESEARCH (2017)
Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts
Sang Wan Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
The Lrp4 R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans
Eveline Boudin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Effect of pioglitazone on the calcification of rat vascular smooth muscle cells through the downregulation of the Wnt/β-catenin signaling pathway
Min Gao et al.
MOLECULAR MEDICINE REPORTS (2017)
Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D
Xue-Rong Wang et al.
NEPHROLOGY (2017)
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
Kenneth G. Saag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes
Soohyun P. Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Suppression of Wnt Signaling and Osteogenic Changes in Vascular Smooth Muscle Cells by Eicosapentaenoic Acid
Yukihiro Saito et al.
NUTRIENTS (2017)
Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice
Eric E. Beier et al.
BONE RESEARCH (2017)
Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells
Soon-Youn Choi et al.
PLOS ONE (2017)
Sost deficiency led to a greater cortical bone formation response to mechanical loading and altered gene expression
David Pflanz et al.
SCIENTIFIC REPORTS (2017)
Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways
Megan M. Weivoda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Bisphosphonates for cardiovascular risk reduction: A systematic review and meta-analysis
Guido Kranenburg et al.
ATHEROSCLEROSIS (2016)
Wnt signaling contributes to vascular calcification by induction of matrix metalloproteinases
Christian Freise et al.
BMC CARDIOVASCULAR DISORDERS (2016)
How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
Isabelle Piec et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Secreted Frizzled-Related Protein 5 Attenuates High Phosphate-Induced Calcification in Vascular Smooth Muscle Cells by Inhibiting the Wnt/-Catenin Pathway
Dai Deng et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Association of bone-derived biomarkers with vascular calcification in chronic hemodialysis patients
Yueh-Ting Lee et al.
CLINICA CHIMICA ACTA (2016)
WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression
Ting Cai et al.
EXPERIMENTAL CELL RESEARCH (2016)
Aberrant activation of Wnt pathways in arteries associates with vascular calcification in chronic kidney disease
Jingyi Liu et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4
Wei Lv et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
Sclerostin Enhances Adipocyte Differentiation in 3T3-L1 Cells
Mayumi Ukita et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2016)
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study
Luc Chouinard et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Resveratrol Ameliorated Vascular Calcification by Regulating Sirt-1 and Nrf2
P. Zhang et al.
TRANSPLANTATION PROCEEDINGS (2016)
High Serum Sclerostin Levels Are Associated with a Better Outcome in Haemodialysis Patients
Guillaume Jean et al.
NEPHRON (2016)
Association of circulating sclerostin with vascular calcification in Afro-Caribbean men
Allison L. Kuipers et al.
ATHEROSCLEROSIS (2015)
Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx
Carmen Herencia et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients
P. Evenepoel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?
Albina Nowak et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2015)
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Abdul Rashid Qureshi et al.
KIDNEY INTERNATIONAL (2015)
Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications
Chih-Yu Yang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications
Marion Morena et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
S. Pelletier et al.
OSTEOPOROSIS INTERNATIONAL (2015)
The Role and Mechanism of α-Klotho in the Calcification of Rat Aortic Vascular Smooth Muscle Cells
Tianlei Chen et al.
BIOMED RESEARCH INTERNATIONAL (2015)
High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
Christiane Drechsler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Differential miRNA Expression in Cells and Matrix Vesicles in Vascular Smooth Muscle Cells from Rats with Kidney Disease
Praneet Chaturvedi et al.
PLOS ONE (2015)
Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
Dae Hyun Kim et al.
PLOS ONE (2015)
Sclerostin inhibits osteoblast differentiation without affecting BMP2/SMAD1/5 or Wnt3a/β-catenin signaling but through activation of platelet-derived growth factor receptor signaling in vitro
Cyril Thouverey et al.
BONEKEY REPORTS (2015)
Canonical Wnt Signaling Induces Vascular Endothelial Dysfunction via p66Shc-Regulated Reactive Oxygen Species
Ajit Vikram et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Cholesterol modulates LRP5 expression in the vessel wall
M. Borrell-Pages et al.
ATHEROSCLEROSIS (2014)
Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature
Silje Rafaelsen et al.
BMC GENETICS (2014)
Vascular Calcification in Chronic Kidney Disease is Induced by Bone Morphogenetic Protein-2 via a Mechanism Involving the Wnt/beta-Catenin Pathway
Shu Rong et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Intracranial calcification in childhood: a review of aetiologies and recognizable phenotypes
John H. Livingston et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2014)
Tissue-Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody
Michael S. Ominsky et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Effects of Estrogen on Bone mRNA Levels of Sclerostin and Other Genes Relevant to Bone Metabolism in Postmenopausal Women
Koji Fujita et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Serum Dickkopf 1 Levels in Sclerostin Deficiency
A. H. van Lierop et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Role of Wnt/β-catenin signaling pathway in the mechanism of calcification of aortic valve
Gang-jian Gu et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2014)
Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients
Pierre Delanaye et al.
NEPHRON CLINICAL PRACTICE (2014)
Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells
Addy Montes de Oca et al.
PLOS ONE (2014)
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
Flavia Leticia Carvalho Goncalves et al.
BMC NEPHROLOGY (2014)
The Relation between Renal Function and Serum Sclerostin in Adult Patients with CKD
Solenne Pelletier et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
Sonia Morales-Santana et al.
DIABETES CARE (2013)
High Mobility Group Box 1 (HMGB1) Mediates High-Glucose-Induced Calcification in Vascular Smooth Muscle Cells of Saphenous Veins
Yongyi Wang et al.
INFLAMMATION (2013)
Van Buchem disease: Clinical, biochemical, and densitometric features of patients and disease carriers
Antoon H. van Lierop et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Sclerostin Regulates Release of Bone Mineral by Osteocytes by Induction of Carbonic Anhydrase 2
Masakazu Kogawa et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy
Rafael Kramann et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
Liesbeth Viaene et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Aortic valve calcification in chronic kidney disease
Marcello Rattazzi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification
Sandy Chan Hsu et al.
NEUROGENETICS (2013)
Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study
J. -H. Kang et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Vincent M. Brandenburg et al.
BMC NEPHROLOGY (2013)
Generalized Arterial Calcification of Infancy and Pseudoxanthoma Elasticum Can Be Caused by Mutations in Either ENPP1 or ABCC6
Yvonne Nitschke et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Leptin promotes osteoblast differentiation and mineralization of primary cultures of vascular smooth muscle cells by inhibiting glycogen synthase kinase (GSK)-3β
Melec G. Zeadin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Three decades of Wnts: a personal perspective on how a scientific field developed
Roel Nusse et al.
EMBO JOURNAL (2012)
Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation
Hai Qing et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
Yves Sabbagh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
SCLEROSTIN AS POTENTIAL NOVEL BIOMARKER FOR AORTIC VALVE CALCIFICATION
Ralf Koos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients
Daniel Cejka et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells
Estelle Woldt et al.
NATURE COMMUNICATIONS (2012)
In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation
Julio M. Martinez-Moreno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans
Alexandre Marchand et al.
AGING CELL (2011)
Arterial Calcification in Chronic Kidney Disease: Key Roles for Calcium and Phosphate
Catherine M. Shanahan et al.
CIRCULATION RESEARCH (2011)
Impact of WNT signaling on tissue lineage differentiation in the early mouse embryo
Satomi S. Tanaka et al.
DEVELOPMENT GROWTH & DIFFERENTIATION (2011)
Wnt signaling in macrophages: Augmenting and inhibiting mycobacteria-induced inflammatory responses
Kolja Schaale et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2011)
Single-Dose, Placebo-Controlled, Randomized Study of AMG 785, a Sclerostin Monoclonal Antibody
Desmond Padhi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Sclerostin Is a Locally Acting Regulator of Late-Osteoblast/Preosteocyte Differentiation and Regulates Mineralization Through a MEPE-ASARM-Dependent Mechanism
Gerald J. Atkins et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Cell biological and physicochemical aspects of arterial calcification
Ellen Neven et al.
KIDNEY INTERNATIONAL (2011)
Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin
Wei Wei et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
NT5E Mutations and Arterial Calcifications
Cynthia St Hilaire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prostaglandin E2 Signals Through PTGER2 to Regulate Sclerostin Expression
Damian C. Genetos et al.
PLOS ONE (2011)
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Asiri R. Wijenayaka et al.
PLOS ONE (2011)
Chondrocyte Rather Than Osteoblast Conversion of Vascular Cells Underlies Medial Calcification in Uremic Rats
Ellen Neven et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Activation of Vascular Smooth Muscle Parathyroid Hormone Receptor Inhibits Wnt/β-Catenin Signaling and Aortic Fibrosis in Diabetic Arteriosclerosis
Su-Li Cheng et al.
CIRCULATION RESEARCH (2010)
The syndromic status of sclerosteosis and van Buchem disease
P. Beighton et al.
CLINICAL GENETICS (2010)
Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
Carola Krause et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Wnt5a Induces Endothelial Inflammation via β-Catenin-Independent Signaling
Jihun Kim et al.
JOURNAL OF IMMUNOLOGY (2010)
Coronary Calcification in Patients with Chronic Kidney Disease and Coronary Artery Disease
Satoko Nakamura et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Vascular calcification and bone disease: the calcification paradox
Veerle Persy et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Degradation of MEPE, DMP1, and release of SIBLING ASARM-Peptides (Minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP
Aline Martin et al.
ENDOCRINOLOGY (2008)
Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs)
Zhaodi Gong et al.
FASEB JOURNAL (2008)
Extracellular transglutaminase 2 activates β-catenin signaling in calcifying vascular smooth muscle cells
Lidia Faverman et al.
FEBS LETTERS (2008)
Matrix mineralization as a trigger for osteocyte maturation
Kazuharu Irie et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin
Alexander G. Robling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein α and peroxisome proliferator-activated receptor γ
Sona Kang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Wnt1 and Wnt5a affect endothelial proliferation and capillary length; Wnt2 does not
Anne M. Goodwin et al.
GROWTH FACTORS (2007)
Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols
V. Shalhoub et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
Cultured endothelial cells display endogenous activation of the canonical Wnt signaling pathway and express multiple ligands, receptors, and secreted modulators of Wnt signaling
Anne M. Goodwin et al.
DEVELOPMENTAL DYNAMICS (2006)
Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells
Orit Kollet et al.
NATURE MEDICINE (2006)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
Essential role of β-catenin in postnatal bone acquisition
SL Holmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of osteoblastogenesis and bone mass by Wnt10b
CN Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MEPE has the properties of an osteoblastic phosphatonin and minhibin
PSN Rowe et al.
BONE (2004)
The wrickkened pathways of FGF23, MEPE and PHEX
PSN Rowe
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE (2004)
FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo
J Ezan et al.
CARDIOVASCULAR RESEARCH (2004)
Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation
MK Sutherland et al.
BONE (2004)
Mesenchymal stem cells can be differentiated into endothelial cells in vitro
J Oswald et al.
STEM CELLS (2004)
Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification
F Rutsch et al.
NATURE GENETICS (2003)
Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E
K Magoori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
beta-catenin is expressed aberrantly in tumors expressing shadow cells - Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst
AM Hassanein et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Matrix metalloproteinase-dependent activation of latent transforming growth factor-β controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis
MA Karsdal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mutations in ANKH cause chondrocalcinosis
A Pendleton et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Inhibition of MEPE cleavage by Phex
R Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population
K Staehling-Hampton et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
W Balemans et al.
JOURNAL OF MEDICAL GENETICS (2002)
The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation
V Everts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia
PSN Rowe et al.
GENOMICS (2000)
Share Paper
